Suppr超能文献

乌梅丸早期给药通过PI3K/Akt信号通路和氨基酸代谢抑制髓源性抑制细胞,以预防结肠炎相关结直肠癌。

Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.

作者信息

Lu Zhi-Hua, Ding Yang, Wang Yu-Ji, Chen Chen, Yao Xing-Ran, Yuan Xiao-Min, Bu Fan, Bao Han, Dong Yu-Wei, Zhou Qiao, Li Lu, Chen Tuo, Li Yang, Zhou Jin-Yong, Wang Qiong, Shi Guo-Ping, Jiang Feng, Chen Yu-Gen

机构信息

The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210029, China.

出版信息

J Ethnopharmacol. 2024 Oct 28;333:118260. doi: 10.1016/j.jep.2024.118260. Epub 2024 Apr 27.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Wumei Wan (WMW), a traditional Chinese medicine prescription, has been proved to be effective in treating Colitis-associated colorectal cancer (CAC), but it has not been proven to be effective in different stages of CAC.

AIM OF THE STUDY

The purpose of our study is to investigate the therapeutic effect and mechanism of WMW on the progression of CAC.

MATERIALS AND METHODS

Azioximethane (AOM) and dextran sulfate sodium (DSS) were used to treat mice for the purpose of establishing CAC models. WMW was administered in different stages of CAC. The presentative chemical components in WMW were confirmed by LC-MS/MS under the optimized conditions. The detection of inflammatory cytokines in the serum and colon of mice were estimated by qRT-PCR and ELISA. The changes of T cells and myeloid-derived suppressor cells (MDSCs) in each group were detected by flow cytometry. The metabolic components in serum of mice were detected by UPLC-MS/MS. Expression of genes and proteins were detected by eukaryotic transcriptomics and Western blot to explore the key pathway of WMW in preventing CAC.

RESULTS

WMW had significant effect on inhibiting inflammatory responses and tumors during the early development stage of CAC when compared to other times. WMW increased the length of mice's colons, reduced the level of IL-1β, IL-6, TNF-α in colon tissues, and effectively alleviated colonic inflammation, and improved the pathological damage of colon tissues. WMW could significantly reduce the infiltration of MDSCs in the spleen, increase CD4 T cells and CD8 T cells in the spleen of CAC mice, and effectively reform the immune microenvironment in CAC mice. Transcriptomics analysis revealed that 2204 genes had different patterns of overlap in the colon tissues of mice between control group, AOM + DSS group, and early administration of WMW group. And KEGG enrichment analysis showed that PI3K/Akt signaling pathway, ECM-receptor interaction, IL-17 signaling pathway, MAPK signaling pathway, pancreatic secretion, thermogenesis, and Rap1 signaling pathway were all involved. The serum metabolomics results of WMW showed that the metabolic compositions of the control group, AOM + DSS group and the early stage of WMW were different, and 42 differential metabolites with the opposite trends of changes were screened. The metabolic pathways mainly included pyrimidine metabolism, glycine, serine and threonine metabolism, tryptophan metabolism, and purine metabolism. And amino acids and related metabolites may play an important role in WMW prevention of CAC.

CONCLUSION

WMW can effectively prevent the occurrence and development of CAC, especially in the initial stage. WMW can reduce the immune infiltration of MDSCs in the early stage. Early intervention of WMW can improve the metabolic disorder caused by AOM + DSS, especially correct the amino acid metabolism. PI3K/Akt signaling pathway was inhabited in early administration of WMW, which can regulate the amplification and function of MDSCs.

摘要

民族药理学相关性

乌梅丸(WMW)是一种中药方剂,已被证明对治疗结肠炎相关结直肠癌(CAC)有效,但尚未被证明在CAC的不同阶段均有效。

研究目的

本研究旨在探讨乌梅丸对CAC进展的治疗作用及其机制。

材料与方法

使用氧化偶氮甲烷(AOM)和葡聚糖硫酸钠(DSS)处理小鼠以建立CAC模型。在CAC的不同阶段给予乌梅丸。在优化条件下通过液相色谱-串联质谱(LC-MS/MS)确认乌梅丸中的代表性化学成分。通过定量逆转录聚合酶链反应(qRT-PCR)和酶联免疫吸附测定(ELISA)评估小鼠血清和结肠中炎性细胞因子的检测情况。通过流式细胞术检测每组中T细胞和髓源性抑制细胞(MDSC)的变化。通过超高效液相色谱-串联质谱(UPLC-MS/MS)检测小鼠血清中的代谢成分。通过真核转录组学和蛋白质免疫印迹法检测基因和蛋白质的表达,以探索乌梅丸预防CAC的关键途径。

结果

与其他时期相比早,乌梅丸在CAC早期发育阶段对抑制炎症反应和肿瘤具有显著作用。乌梅丸增加了小鼠结肠长度,降低了结肠组织中白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平,有效减轻了结肠炎症,改善了结肠组织的病理损伤。乌梅丸可显著减少脾脏中MDSC的浸润,增加CAC小鼠脾脏中CD4 T细胞和CD8 T细胞,有效重塑CAC小鼠的免疫微环境。转录组学分析显示,对照组、AOM + DSS组和早期给予乌梅丸组小鼠的结肠组织中有2204个基因具有不同的重叠模式。京都基因与基因组百科全书(KEGG)富集分析表明,磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)信号通路、细胞外基质-受体相互作用、白细胞介素-17(IL-17)信号通路、丝裂原活化蛋白激酶(MAPK)信号通路、胰腺分泌、产热和Rap1信号通路均参与其中。乌梅丸的血清代谢组学结果表明,对照组、AOM + DSS组和乌梅丸早期组的代谢成分不同,并筛选出42种变化趋势相反的差异代谢物。代谢途径主要包括嘧啶代谢、甘氨酸、丝氨酸和苏氨酸代谢、色氨酸代谢和嘌呤代谢。氨基酸及相关代谢物可能在乌梅丸预防CAC中起重要作用。

结论

乌梅丸可有效预防CAC的发生和发展,尤其是在初始阶段。乌梅丸可在早期减少MDSC的免疫浸润。乌梅丸的早期干预可改善AOM + DSS引起的代谢紊乱,尤其是纠正氨基酸代谢。早期给予乌梅丸可抑制PI3K/Akt信号通路,该通路可调节MDSC的扩增和功能。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验